
Abstract: The goal ofpostmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin replacement. The purpose of this review is to describe the risks and benefits of hormonal therapy, focusing on estradiol/norethindrone acetate combination therapy.
Estradiol, Estrogen Replacement Therapy, RC952-954.6, Breast Neoplasms, Venous Thromboembolism, Contraceptives, Oral, Synthetic, Risk Assessment, Stroke, Drug Combinations, Norethindrone Acetate, Geriatrics, Bone Density, Memory, Endometrial Hyperplasia, Humans, Female, Norethindrone, Colorectal Neoplasms
Estradiol, Estrogen Replacement Therapy, RC952-954.6, Breast Neoplasms, Venous Thromboembolism, Contraceptives, Oral, Synthetic, Risk Assessment, Stroke, Drug Combinations, Norethindrone Acetate, Geriatrics, Bone Density, Memory, Endometrial Hyperplasia, Humans, Female, Norethindrone, Colorectal Neoplasms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
